ReviewFrontiers in immunology2020

Chimeric Antigen Receptor T Cell Therapy for Pediatric B-ALL: Narrowing the Gap Between Early and Long-Term Outcomes.

Liora SchultzPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.